
|Articles|December 6, 2018
Risk-Based Monitoring in Clinical Trials, 4th Edition
Applied Clinical Trials presents the latest issues that have risen to prominence since RBM adoption grows. This edition presents a well-rounded look at RBM including articles that describe current RBM trends; a survey of European CRAs, which shows the difficulties among sites and monitors with RBM; a comprehensive look at how sponsors and CROs can support their employees in the RBM transition, and closes with a case study on Novartis' use of adaptive monitoring.
Advertisement
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
2
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
3
Breaking Out of AI Pilot Mode in Clinical Development
4
ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
5



